Intracellular FGF1 protects cells from apoptosis through direct interaction with p53

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• Fibroblast Growth Factor 1 (FGF1) is known to signal through cell surface tyrosine kinase receptors.
• Recent findings indicate FGF1 possesses intracellular functions independent of its canonical signaling pathways.
• Intracellular FGF1 has demonstrated anti-apoptotic activity, but the underlying mechanism remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which intracellular FGF1 exerts its anti-apoptotic effects.
• To investigate the role of the tumor suppressor protein p53 in mediating FGF1's protective function against apoptosis.
• To determine if FGF1 directly interacts with p53 within the cell.

Main Methods:

• Cell survival assays using various apoptosis inducers in cells with and without wild-type p53.
• Gene silencing of p53 to assess its necessity for FGF1's anti-apoptotic activity.
• Transfection of p53-negative cells with wild-type p53 to restore FGF1's protective function.
• Co-immunoprecipitation assays to detect direct interaction between FGF1 and p53.

Main Results:

• FGF1 expression enhanced cell survival against apoptosis inducers only in the presence of wild-type p53.
• Loss of p53 rendered cells susceptible to apoptosis, negating the protective effect of FGF1.
• Intracellular FGF1 was shown to directly bind to p53, with the interaction localized to the DNA-binding domain (DBD) of p53.

Conclusions:

• Wild-type p53 is essential for the intracellular anti-apoptotic activity of FGF1.
• Intracellular FGF1 directly interacts with p53, suggesting a novel mechanism for apoptosis regulation.
• FGF1 may protect cells from apoptosis by modulating p53 function through direct physical interaction.